D-0916-2018 Class II Terminated

Recalled by Akorn, Inc. — Decatur, IL

FDA drug recall D-0916-2018 was initiated by Akorn, Inc. on Jun 22, 2018 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Nov 6, 2020). Affected quantity: 89,507 vials.

Recall Details

Product Type
Drugs
Report Date
Jul 18, 2018
Initiation Date
Jun 22, 2018
Termination Date
Nov 6, 2020
Product Quantity
89,507 vials

Product Description

Acetylcysteine for Injection 6 g/30 mL (200 mg/mL). Rx Only. Manufactured by Akron Inc., Lake Forest, IL 60045. NDC 17478-660-30.

Reason for Recall

CGMP Deviations

Distribution Pattern

U.S. Nationwide

Code Information

Lots: 061496A, Exp. 06/2018; 111696A, Exp. 11/2018; 061947A, Exp. 06/2019; 091267A, Exp. 09/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0916-2018
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.